| Before diabetes | Date of DD | After diabetes | ||
---|---|---|---|---|---|
Disease cluster2 | ID year before DD3 | Prevalence at DD, % (95% CI)4 | ID first year after DD3 | ID first 5 years after DD3 | ID first 10 years after DD3 |
Cardiovascular | 176.9 (127.9 to 225.9) | 64.0 (60.4 to 67.5) | 122.3 (77.0 to 167.6) | 105.5 (82.9 to 128.0) | 101.0 (82.1 to 119.9) |
Musculoskeletal | 31.3 (15.5 to 47.1) | 31.1 (27.8 to 34.6) | 21.6 (8.2 to 35.0) | 27.9 (20.1 to 35.8) | 31.6 (24.6 to 38.6) |
Mental | 15.2 (4.7 to 25.8) | 24.1 (21.1 to 27.3) | 5.8 (0.0 to 12.4) | 10.4 (5.9 to 14.8) | 12.6 (8.5 to 16.7) |
Eye and ear | 29.6 (15.1 to 44.0) | 22.7 (19.7 to 25.9) | 46.9 (28.1 to 65.6) | 45.3 (35.7 to 54.9) | 42.8 (34.9 to 50.7) |
Urogenital (male and female) | 23.7 (11.3 to 36.1) | 15.4 (12.9 to 18.2) | 17.6 (6.7 to 28.5) | 16.9 (11.5 to 22.4) | 15.5 (11.2 to 19.8) |
Urogenital5 | 26.7 (8.2 to 45.2) | 13.4 (10.1 to 17.3) | 14.1 (0.3 to 27.9) | 12.8 (6.1 to 19.5) | 14.1 (8.2 to 20.0) |
Urogenital6 | 20.6 (4.1 to 37.0) | 17.4 (13.7 to 21.5) | 21.0 (4.2 to 37.8) | 21.0 (12.4 to 29.6) | 16.9 (10.5 to 23.2) |
Respiratory | 6.8 (0.1 to 13.4) | 14.1 (11.7 to 16.9) | 3.4 (0.0 to 8.2) | 4.3 (1.6 to 6.9) | 3.8 (1.7 to 5.8) |
Skin | 8.0 (1.0 to 15.1) | 9.9 (7.9 to 12.3) | 1.6 (0.0 to 4.8) | 3.8 (1.3 to 6.3) | 3.1 (1.3 to 5.0) |
Digestive | 3.2 (0.0 to 7.5) | 8.5 (6.7 to 10.8) | 3.2 (0.0 to 7.7) | 3.7 (1.3 to 6.1) | 4.0 (1.9 to 6.1) |
Endocrine and metabolic | 9.4 (1.9 to 17.0) | 8.4 (6.5 to 10.6) | 4.8 (0.0 to 10.3) | 6.7 (3.4 to 9.9) | 5.7 (3.2 to 8.2) |
Malignancies | 14.0 (4.8 to 23.1) | 7.3 (5.5 to 9.4) | 14.4 (5.0 to 23.7) | 15.9 (10.9 to 20.9) | 17.5 (13.2 to 21.9) |
Neurologic | 1.5 (0.0 to 4.4) | 3.4 (2.2 to 4.9) | 1.5 (0.0 to 4.5) | 2.0 (0.2 to 3.7) | 1.9 (0.5 to 3.3) |
Blood and lymphatics | 4.4 (0.0 to 9.3) | 0.4 (0.1 to 1.1) | 0.0 | 1.5 (0.0 to 3.0) | 1.6 (0.3 to 2.8) |
Infectious | 0.0 | 0.3 (0.0 to 0.9) | 0.0 | 0.0 | 0.0 |